Ask the CAR T-cell Experts
Tuesday, October 21st, 2025
7 pm eastern, 6 pm central, 5 pm mountain, 4 pm pacific
You will learn:
- which diseases are currently treated with CAR T-cell therapy
- who is a good candidate for CAR T-cell therapy
- what to expect before, during, and after CAR T-cell therapy
- whether CAR T-cell therapy actually cures cancer
- advances in CAR T-cell therapy that are on the horizon
Submit up to three questions when you register for this event. Our panel of experts will answer as many questions as possible during the live online webinar.
Register and submit your questions now!
Meet the Speakers
Dr. Diana Cirstea is a hematologist-oncologist at the Mass General Brigham Cancer Center, a faculty member at Harvard Medical School, and part of the Massachusetts General Hospital Multiple Myeloma Program. She is an expert in CAR T-cell therapy for patients with multiple myeloma.
Dr. Rawan Faramand is a medical oncologist at Moffit Cancer Center where she specializes in Blood and Marrow Transplantation and Cellular Immunotherapy. Dr. Faramand is an expert in CAR T-cell therapy for patients with acute lymphoblastic leukemia (ALL).
Dr. Jay Spiegel is an Assistant Professor at the Miami Miller School of Medicine and a hematologist in the Transplant and Cellular Therapy Division of the University of Miami Sylvester Comprehensive Cancer Center. He is an expert in CAR T-cell therapy for patients with B-cell malignancies such as lymphoma.
Ms. Franzetti is a licensed clinical social worker, specializes in supporting individuals and families affected by blood cancers, with a focus on CAR T-cell therapy survivors. With extensive experience before and after treatment, she understands the unique challenges patients face and is passionate about promoting emotional and social well-being in cancer care. She currently leads BMT InfoNet's CAR T-cell support groups.
